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Assessment of myocardial oxidative metabolism 
in aortic valve disease using positron emission 
tomography with C-l 1 acetate 
C-l 1 acetate has recently been introduced as a tracer of myocardial oxidative metabolism with 
the use of positron emission tomography. To evaluate this approach in the pressure- or 
volume-loaded heart, C-l 1 acetate clearance rate constants were determined in 22 patients with 
chronic aortic valve disease and in nine normal subjects. Global myocardial C-l 1 clearance was 
significantly higher in patients with predominant aortic stenosis (n = 11) or aortic regurgitation 
(n = 11) than in normal subjects (0.06s t 0.017 mine1 and 0.072 + 0.010 min-’ compared with 
0.050 ?I 0.004 min-‘, p < 0.05) and correlated significantly with the rate-pressure product 
corrected for mean aortic valve gradient (r = 0.73, p = 0.0001) for all studies. However, analysis 
of patient subgroups demonstrated that this correlation held only for aortic stenosis (r = 0.79, 
p < 0.005 for gradient-corrected rate-pressure product). Additionally, C-l 1 clearance was 
strongly correlated with the product of heart rate and mean wall stress in patients with aortic 
stenosis (r = 0.89, p < 0.005) but not in patients with aortic regurgitation. Normalization of C-l 1 
acetate clearance rate constants for gradient-corrected rate-pressure product were significantly 
lower in patients with loaded ventricles, particularly in the presence of a low ejection fraction, 
compared to normal subjects. Possible mechanisms include myocardlal adaptation through 
hypertrophy or depressed contractility, which would both tend to reduce oxygen consumption 
under any given load. Serial comparison of C-l 1 acetate kinetics and noninvasive indexes of 
oxygen demand may provide assessment of disease progression in pathologic ventricular 
loading. (AM HEART J lgg2;123:653.) 
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Assessment of myocardial oxygen consumption has 
formerly required complex and invasive techniques. 
However, noninvasive characterization of myocardial 
oxidative metabolism has recently become possible 
with the introduction of C-11 acetate as a metabolic 
tracer for use with positron emission tomography.1-3 
Results of experimental studies in animals have 
demonstrated that C-11 acetate is taken up avidly by 
the myocardium and that subsequent clearance of 
C-11 activity from the heart is strongly correlated 
with myocardial oxygen consumption per unit mass 
of tissue (MVOs). 4! 5 These promising results have led 
to the evaluation of this agent as a tracer of oxidative 
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metabolism in humans. In normal subjects studied at 
rest and during exercise6 and at rest and during dob- 
utamine infusion,7 there was a close correlation 
between C-11 acetate clearance rate constants and 
the rate-pressure product. This parameter is itself a 
validated correlate of myocardial oxygen consump- 
tion by the normal human heart.8-10 Besides being a 
means to directly and noninvasively assess myocar- 
dial oxygen consumption, C-11 acetate clearance ki- 
netics also provide assessment of regional variation in 
oxidative metabolism.ll This facility is unique since 
invasive assessment of myocardial oxygen consump- 
tion only provides assessment of global oxygen ex- 
traction. Results of these validation studies in normal 
humans suggest that C-11 acetate may be a useful 
experimental tool for evaluating oxidative metabo- 
lism in cardiac disease. However, reports of the util- 
ity of this method for the evaluation of pathologic 
conditions of the heart have been limited to a study 
involving a small number of patients after myocar- 
dial infarction.12 
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Fig. 1. Dynamic series of decay-corrected C-11 acetate images displayed in single midventricular 
transaxial plane. In the first frame (top left) C-11 activity is mainly in blood. Later there is rapid blood 
pool clearance and avid myocardial extraction. By the final frame (bottom right) there has been substan- 
tial clearance of myocardial C-11 activity, reflecting metabolism of C-11 acetate via tricarboxylic acid cy- 
cle. 
In this study we evaluated the use of positron 
emission tomography with C-11 acetate in 22 pa- 
tients with chronic aortic valve disease to compare 
C-11 acetate clearance kinetics in the pressure- and 
volume-loaded heart with those found in normal 
subjects, assess the homogeneity of oxidative metab- 
olism within the loaded ventricle, and determine the 
relationship between C-11 acetate clearance and 
routinely available hemodynamic and echocardio- 
graphic parameters of left ventricular oxygen de- 
mand. 
METHODS 
Study population. The study protocol was approved by 
the Human Subject Protection Committee of the Univer- 
sity of Michigan Medical Center. All patients and normal 
control subjects were studied only after they granted 
informed written consent. The patient population included 
22 patients (14 men and eight women) with chronic aortic 
valve disease and no evidence of coronary artery disease. 
These patients were between the ages of 34 and 85 years 
and were being considered for aortic valve replacement. All 
were clinically stable and had no change in medications 
during the study interval. Elective coronary angiography 
had been performed in all patients within 1 month of the 
positron emission tomography. None had coronary stenoses 
of greater than 50% of the luminal diameter or regional 
wall motion abnormalities suggesting prior myocardial in- 
farction. 
Patients were classified as having either predominant 
aortic stenosis or aortic regurgitation based on their clin- 
ical diagnosis, which incorporated a knowledge of physical 
examination, echocardiographic, and cardiac catheteriza- 
tion findings. Eleven patients were considered to have pre- 
dominant aortic stenosis and 11 were considered to have 
aortic regurgitation as the dominant valvular lesion. Pa- 
tients were compared with nine healthy male volunteers, 22 
to 28 years of age. These subjects had no known cardiac 
disease based on clinical history, physical examination re- 
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Fig. 2. Typical C-11 acetate time-activity curve (corrected for decay) displayed for left ventricular my- 
ocardial region of interest. Early rapid clearance phase of myocardial clearance curve was fitted by means 
of least-squares monoexponential curve fitting routine. Lower curve representsblood pool activity, which 
decreases rapidly and substantially early after intravenous administration. 
sults, and ECG findings. All were considered to be at low 
risk for coronary artery disease. Echocardiographic studies 
were performed in four of these subjects and results were 
normal. 
Noninvasive assessment of left ventricular oxygen 
demand. The rate-pressure product and left ventricu- 
lar wall stress are readily available and commonly used 
noninvasive parameters of left ventricular oxygen de- 
mand.s-10,13 Heart rate and cuff systolic blood pressure 
values obtained at the beginning of the C-11 acetate 
positron emission tomographic study were multiplied to 
calculate the rate-pressure product. In patients with aortic 
stenosis, the brachial systolic blood pressure value may 
underestimate left ventricular systolic pressure and conse- 
quently a correction was made for the aortic valve gradient 
in determination of the rate-pressure product. In all 
patients with evidence of aortic stenosis, the sum of the 
systolic blood pressure and the mean aortic valve gradient 
was used as an approximation of left ventricular systolic 
pressure. A “gradient-corrected” rate-pressure product 
was then obtained by multiplying the heart rate at the time 
of the positron emission tomography by this parameter. 
All patients had undergone echocardiography shortly 
before the positron emission tomographic study. In 15 pa- 
tients positron emission tomography and echocardiography 
were done within 24 hours of each other. Among the seven 
remaining patients, the interval between the studies was 
less than 1 week in three patients and less than 6 weeks in 
four (range 4 to 40 days). The mean aortic pressure gradi- 
ent was calculated by integrating the Doppler peak aortic 
flow velocity spectral envelope.i4 The left ventricular ejec- 
tion fraction was determined by two-dimensional echocar- 
diography with Simpson’s rule in the 20 patients.i5 A left 
ventricular ejection fraction of less than 50 % was consid- 
ered abnormal. In patients with technically adequate 
echocardiograms for assessment of wall thickness and left 
ventricular dimensions (n = 18), mean left ventricular wall 
stress index16 and left ventricular mass17 were also calcu- 
lated. Comparisons were made with four normal subjects 
who had undergone echocardiographic studies. 
Positron emission tomography with C-l 1 acetate. C-11 
acetate was synthesized by means of a modification of pre- 
viously described meth0ds.l All C-11 acetate studies were 
performed with a whole-body positron emission tomogra- 
phy scanner (Siemens 931, Siemens Gammasonics Inc., 
Hoffmann Estates, Ill.), which allows simultaneous imag- 
ing of 15, transaxial slices, 6.75 mm thick. Transmission 
images were obtained for 15 minutes and were used to cor- 
rect for the effects of tissue attenuation on the emission 
images. Dynamic positron emission tomographic imaging 
was then performed for 31 minutes after intravenous 
administration of 740 MBq (20 mCi) of C-11 acetate. Ten 
frames of 90 seconds’ duration were obtained, followed by 
five frames of 120 seconds’ duration and two frames of 180 
seconds’ duration. 
A single midventricular transverse transaxial plane was 
chosen from the 15 available planes. The decay-corrected 
dynamic series of C-11 acetate images for this plane was 
displayed, and regions of interest were assigned on the 
frame with the best myocardial definition. Generally this 
was approximately 4 to 6 minutes after administration of 
the tracer (Fig. 1). Myocardial regions were assigned for the 
septum, anterior wall, and free lateral wall. For consistency 
between studies, the apical left and right ventricular junc- 
tion and the posteromedial papillary muscle were used as 
arbitrary landmarks demarcating these regions. An addi- 
tional region of interest was assigned for the entire left 
ventricular myocardium in this plane. These regions of in- 
terest were then extrapolated to all frames of the dynamic 
series, thereby defining regional and global left ventricular 
myocardial time-activity curves (Fig. 2). Monoexponential 
least-squares curve fitting of the early rapid phase of my- 
ocardial clearance was used to derive C-11 clearance half- 
times in seconds6 C-11 clearance rate constants (k min-l) 
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HR Mean AoV corrected RPP 
(bea tsl gradient (beatslmin. LVEDD 




Patients with aortic stenosis 
1237 Moderate AS, mild AR 
3026 Severe AS 
3698 Moderate AS, mild AR 
5307 Severe AS 
5855 Moderate AS 
6808 Moderate AS 
6869 Severe AS, mild AR 
7124 Moderate AS, mild AR 
7818 Severe AS, moderate AR 
7840 Severe AS, mild MR, mild 
AR 
9855 Severe AS 
Patients with aortic regurgitation 
1313 Moderate AR, MS, mild AS 
2531 Severe AR 
2573 Mild AR, mild MR 
4463 Severe AR, mild-moderate AS 
and MR 
5417 Mild-moderate AR, mild AS 
6157 Severe AR 
7006 Moderate AR, severe MR 
9313 Moderate-severe AR 
8285 Severe AR 
9899 Moderate-severe AR 









































































72 23 10,152 
73 50 11,242 
62 49 10,726 
66 61 12,606 
58 22 9,396 
96 48 14,976 
91 55 15,197 
67 56 12,998 
62 67 11,718 
48 79 11.568 























17,922 54.0 45 0.0785 
9,010 69.0 60 0.0623 
9,072 64.0 63 0.0622 

































































Echo, Echocardiography; AS, aortic stenosis; AR, aortic regurgitation; MS, mitral stenosis; MR, mitral regurgitation; AoV, aor& valve; HR, heart rate; LVEF, 
left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; k min -I, C-11 acetate clearance rate constant. 
were obtained by dividing the natural logarithm of two by 
the C-11 clearance half-time in minutes. In animal studies 
C-11 acetate clearance rate constants have been shown to 
be directly proportional to myocardial oxygen consump- 
tion in milliliters per minute per gram of tissue4* 5 and are 
thus independent of left ventricular mass. 
Statistical analysis. Values for groups are presented as 
mean + one standard deviation. Mean values of continu- 
ous factors were compared for the two patient subgroups by 
means of unpaired t tests. Pearson’s correlation was used 
to test the association of two continuous factors. Analysis 
of variance was performed to assess differences between 
patient and normal subject populations. Comparison of re- 
gional C-11 acetate clearance rate constants within indi- 
vidual subjects was performed with analysis of variance for 
repeated measures by means of Scheffe’s F test method. 
Probability levels of <0.05 were considered statistically 
significant. 
RESULTS 
Population characteristics. Data for individual pa- 
tients and normal subjects are displayed in Table I. 
The clinical, hemodynamic, and echocardiographic 
data characterizing each of the subgroups in the 
study are presented in Table II. In both groups of 
patients the gradient-corrected rate-pressure prod- 
uct was significantly higher than the rate-pressure 
product in the normal subjects. Patients with aortic 
regurgitation had significantly higher left ventricular 
end-diastolic diameters than patients with aortic 
stenosis, but left ventricular wall stress, mass, and 
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‘PcO.05 compared with Aortic Stenosis and Aortic Regurgitation 
Fig, 3. Average C-11 acetate clearance rate constants in patients with either predominant aortic stenosis 
or predominant aortic regurgitation were significantly higher than values in normal subjects. Mean values 
(hatched circles) and standard deviation for each group are displayed. 
NORMAL SUBJECTS AORTIC VALVE DISEASE 
PATIENTS 
ANTERIOR ANTERIOR 
+ 0.006 + 0.010 LATERAL 
* p c 0.05 vs SEPTUM 
Fig. 4. Myocardial regions of interest were defined for septum, anterior wall, and lateral wall of left ven- 
tricle on single midventricular plane. Apical junction of left and right ventricles was used as border between 
septum and anterior wall. Posteromedial papillary muscle was used as junction of anterior and lateral walls. 
Average regional C-11 clearance rate constant data from nine normal subjects are presented on the left and 
from all patients with aortic valve disease on the right. Regional C-11 acetate clearance rate constants were 
not significantly different between patients with pressure or volume overload but were significantly higher 
in all regions compared with those values recorded in normal subjects (p < 0.05). 
ejection fractions were not significantly different in the patient population, global left ventricular C-11 
the two patient subgroups. acetate clearance rate constants in patients with ei- 
Global C-11 acetate clearance rate constants by ther pressure or volume overload were significantly 
group. There was greater variation of global C-11 ac- higher than the rate constants in normal subjects. 
etate clearance rate constants within both patient C-11 acetate clearance rate constants averaged 
subgroups than in the normal subjects. As expected 0.069 f 0.017 mine1 for patients with predominant 
under the conditions of increased loading observed in aortic stenosis and 0.072 +- 0.010 min-l for patients 
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Table II. Characteristics of patients and normal subjects by diagnostic subgroup 
Group N 
Aortic stenosis 11 
Aortic regurgitation 11 
Normal subjects 9 
&e 
fyr) 
68 + lO* 
58 z!I 15* 







74 + 21 
75 f 14* 




50 t 17t 
8 k 12 
Gradient- 
corrected RPP 
(beatslmin mm Hg) 
13,047 + 3,750* 
11,493 rt 2,976* 
6,292 iz 544 
HR, Heart rate; AoV, aortic valve; RPP, rate-pressure product (heart rate x [systolic blood pressure + mean AoV gradient]); LVEF, left ventricular ejection 
fraction; LVEDD, left ventricular end-diastolic dimension; LV, left ventricular; k min-‘, global C-11 acetate clearance rate constant. 
*p < 0.05 compared with normal subjects. 
tp < 0.05 compared with patients with predominant aortic regurgitation. 
Table Ill. Characteristics of patients and normal subjects by left ventricular ejection fraction subgroup 
Group 
Gradient- 
Mean AoV corrected RPP 
Age HR gradient (beatslmin. LVEDD* 
N (yr) AS:AR (beatslmin) (mm Hd mm Hs) (normal 37-57 mm) 
LVEF 2 50% 15 62 t 137 83 68 * 113 32 + 29 11,529 + 2,1077,$ 58 t- 10 
LVEF < 50% 5 72 t 7t 3:2 93 rt 2ot 33 + 12 15,477 + 5,168 59 c 12 
Normal subjects 9 25t 3 0:o 57f 7 6,292 ‘- 544 - 
HR, Heart rate; AoV, aortic valve; RPP, rate-pressure product (heart rate x [systolic blood pressure + mean AoV gradient]); LVEP, left ventricular ejection 
fraction; LVEDD, left ventricular end-diastolic dimension; LV, left ventricular; k min-‘, global C-11 acetate clearance rate constant. 
*Echocardiographic data from 12 patients with LVEF ~50% and four patients with LVEF >50%. 
tp < 0.05 compared with normal subjects. 
$p < 0.05 compared with patients with LVEF <509,. 
with predominant aortic regurgitation compared with 
0.050 +_ 0.004 min-l in normal subjects (p < 0.05) 
(Fig. 3 and Table II). Although gradient-corrected 
rate-pressure products were slightly higher in pa- 
tients with aortic stenosis than in patients with aor- 
tic regurgitation, C-11 acetate clearance rate con- 
stants were slightly lower on average in the group 
with aortic stenosis. Although neither of these trends 
reached statistical significance, these data emphasize 
that factors other than the rate-pressure product 
may affect myocardial oxygen consumption. 
Regional C-11 acetate clearance rate constants. In 
normal subjects C-11 acetate clearance rate con- 
stants were on average higher in the septal region of 
interest than in the lateral wall. This difference did 
not reach statistical significance. In contrast, C-11 
clearance rate constants were significantly higher in 
the lateral wall than in the septum in patients with 
pathologically loaded ventricles (p < 0.05), although 
the difference was small averaging 8 % . These data 
are presented in Fig. 4. 
Comparison of C-11 acetate clearance with parame- 
ters of left ventricular oxygen demand. If results of all 
studies (patients and normal subjects) were included, 
there was a significant correlation between global 
C-11 acetate clearance rate constants and the gradi- 
ent-corrected rate-pressure product (Fig. 5). Exclu- 
sion of patients with volume overload as a result of 
aortic regurgitation improved the correlation be- 
tween global C-11 acetate clearance rate constants 
and the gradient-corrected rate-pressure product 
and increased the slope of the regression. Indeed 
whereas global C-11 acetate clearance rate constants 
in patients with aortic stenosis were significantly 
correlated with the gradient-corrected rate-pressure 
product values (r = 0.79, p < 0.005), no significant 
correlation was found between these parameters in 
the 11 patients with predominant aortic regurgita- 
tion. Similarly there was a significant but weaker 
correlation between C-11 acetate clearance rate con- 
stants and heart rate for all studies (r = 0.63, 
p < 0.005) and in patients with aortic stenosis 
(r = 0.69, p < 0.05), but not in patients with aortic 
regurgitation as their dominant valve lesion. 
In the 18 patients and four normal subjects from 
whom echocardiographic findings were available, 
C-11 acetate clearance rate constants were loosely 
but significantly correlated with the mean wall stress 
index (r = 0.64, p < 0.005). C-11 acetate clearance 
rate constants were more strongly correlated with the 
product of heart rate and mean wall stress index 
(r = 0.73, p < O.OOl), consistent with the importance 
volume 123 
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65 + 7 
Echo Mean LV 
LVEF wall stress 
(%) index 
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L V mass 
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358 k 136 
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0.075 f  021t 
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4.3 + 0.9$ 
2.3 + 0.41 
4.6 k 0.8 
of heart rate as an index of myocardial oxygen 
demand.iO As with the comparisons between C-11 
acetate clearance rate constants and rate-pressure 
product and with heart rate, a strong correlation was 
observed between C-11 acetate clearance rate con- 
stants and the heart rate-wall stress index products 
for the nine analyzed patients with aortic stenosis 
(r = 0.89, p < 0.005) (Fig. 6), but no significant cor- 
relation was found in the nine patients with aortic 
regurgitation. 
Assuming that C-11 acetate clearance rate con- 
stants reflect myocardial oxygen consumption, the 
relationship between C-11 acetate clearance rate 
constants and noninvasive parameters of oxygen de- 
mand in individual subjects and patients should be 
similar unless that parameter inaccurately reflects 
true oxygen demand in the loaded heart or oxygen 
supply and demand are uncoupled because of is- 
chemia. Accordingly C-11 acetate clearance rate 
constants were normalized for gradient-corrected 
rate-pressure product in all individual studies. Nor- 
malized C-11 clearance rate constants were signifi- 
cantly lower for patients with aortic stenosis than for 
normal subjects (Table II). Normalized C-11 clear- 
ance rate constants in patients with aortic regurgita- 
tion were higher than in patients with aortic stenosis 
but lower than in normal subjects. These differences 
did not reach statistical significance. These data sug- 
gest, however, that the gradient-corrected rate-pres- 
sure product may overestimate oxygen demand in 
chronic overload of the left ventricle and particularly 
in aortic stenosis. Possible mechanisms include my- 
ocardial adaptation to chronic loading by left ven- 
tricular hypertrophy, which would tend to decrease 
wall stresslsp lg and hence oxygen demandI at any 
given pressure load, or as an alternative depressed 
myocardial contractility, which would cause a rela- 
tive decrease in oxygen consumption with respect to 
loading conditions. lo The former possibility is sup- 
ported by the observation that C-11 acetate clearance 
rate constants normalized for the left ventricular wall 
stress index were on average no higher in aortic 
stenosis than in aortic regurgitation (2.62 -+ 0.7 
x 1O-4 vs 2.61 + 0.66 x 10-4, p = NS). 
Comparison of C-l 1 acetate clearance rate constants 
in patients with and without low left ventricular ejection 
fractions. The role of depressed myocardial contrac- 
tility in association with aortic valve disease could 
not be directly assessed in the absence of measured 
parameters of contractility but was indirectly evalu- 
ated by comparing C-11 acetate clearance rate con- 
stants in patients with and without reduced left ven- 
tricular ejection fractions as determined by two- 
dimensional echocardiography in 20 patients (Table 
III). Because most patients (n = 15) had well-pre- 
served ejection fractions and the proportion of pa- 
tients with aortic stenosis and aortic regurgitation in 
each group was not significantly different, all patients 
were combined for this analysis. 
C-11 acetate clearance rate constants were higher 
in patients with left ventricular ejection fractions 
<50% than in those with ejection fractions 250 % 
660 Hicks et al. 
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Fig. 5. Top, Plot of global C-11 clearance rate constants 
(k per minute) versus rate-pressure product corrected for 
mean aortic valve gradient determined by Doppler echocar- 
diography in patients with aortic stenosis (Gradient-cor- 
rected RPP). Significant correlation was noted, although 
considerable scatter around regression line was observed. 
Bottom, Exclusion of patients with aortic regurgitation 
from regression between C-11 acetate clearance rate con- 
stants and gradient-corrected rate-pressure product im- 
proved correlation between these parameters (95 % confi- 
dence bands of the mean value of k min.’ are displayed). 
and normal subjects (Fig. 7 and Table III). However, 
gradient-corrected rate-pressure products and mean 
left ventricular wall stress indexes were also higher in 
patients with depressed ejection fractions and likely 
account for these differences. C-11 acetate clearance 
rate constants normalized for gradient-corrected 
rate-pressure products and for mean left ventricular 
wall stress tended to be lower in patients with low left 
ventricular ejection fractions than for patients with 
preserved left ventricular systolic function. C-11 ac- 
etate clearance rate constants normalized for the 
product of heart rate and mean stress index were not 
significantly different in patients with normal left 
ventricular ejection fractions compared with normal 
subjects. However, C-11 acetate clearance rate con- 
stants normalized for the product of heart rate and 
mean stress index were significantly lower in patients 
with low ejection fractions than in patients with nor- 
mal ejection fractions and normal subjects (2.3 + 
0.4 X 1O-6 vs 4.3 + 0.9 X lop6 and 4.6 + 0.8 x 10e6, 
p < 0.05). These data suggest that depressed con- 
tractility may partially account for the lower than 
expected C-11 acetate clearance rate constants based 
on noninvasive parameters of myocardial oxygen de- 
mand. 
Besides the global changes observed in C-11 ace- 
tate clearance in patients with impaired left ventric- 
ular systolic function, the ratio of septal to lateral 
wall C-11 clearance rate constants was significantly 
lower in patients with low ejection fractions com- 
pared to both normal subjects and patients with nor- 
mal ejection fractions (0.84 & 0.09 vs 1.03 + 0.16 and 
0.95 t 0.07, p < 0.05). 
DISCUSSION 
Myocardial oxidative metabolism represents the 
cellular expression of the diverse effects of load- 
independent and load-dependent determinants of 
myocardial oxygen demand. In the normal heart, 
simple parameters such as the rate-pressure product 
are highly correlated with myocardial oxygen con- 
sumption.8-10 However, changes in ventricular geom- 
etry and contractility in the pathologically loaded 
heart may affect the relationship between myocardial 
oxygen consumption and indirect indexes of oxygen 
demand. This may limit the utility of such measure- 
ments in characterizing myocardial oxidative metab- 
olism under these conditions. The ability to directly 
assess global and regional oxygen consumption with- 
out the need for invasive procedures would have ob- 
vious appeal in this setting. Quantification of C-11 
acetate clearance kinetics by means of positron 
emission tomography potentially provides such eval- 
uation,l, 5, l1 theoretically reflecting all determinants 
of myocardial oxygen demand including heart rate, 
wall stress, and contractility. 
C-l 1 acetate clearance kinetics in the pathologically 
loaded heart. As expected, under the conditions of in- 
creased ventricular loading observed in patients in 
this study, clearance of C-11 activity from the myo- 
cardium in patients with aortic stenosis or regurgita- 
tion was faster than in the hearts of normal subjects, 
suggesting increased myocardial oxygen consump- 
tion (Fig. 3). Although this is further supporting 
evidence that C-11 acetate traces myocardial oxida- 
tive metabolism, the wide variation in C-11 acetate 
clearance rate constants in patients with pressure- or 
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Fig. 6. Plot of global C-11 clearance rate constants versus product of heart rate and mean left ventricular 
wall stress index determined by echocardiography in nine patients with predominant aortic stenosis (left) 
and nine patients with predominant aortic regurgitation (right). Significant correlation was noted in pa- 
tient,s with aortic stenosis (for whom 95 % confidence bands of true mean value of k min-’ are displayed), 
but no significant correlation was noted in patients with aortic regurgitation. 
volume-loaded hearts and the overlap in patients 
with and without evidence of contractile dysfunction 
(Fig. 7) suggest that C-11 acetate clearance rate con- 
stants provide limited useful information when 
viewed in isolation. Inasmuch as myocardial oxygen 
consumption is closely linked to heart rate and pres- 
sure work, normalization of C-11 acetate kinetics to 
predictors of cardiac oxygen demand may provide 
identification of work-independent alterations of 
C-11 acetate kinetics in patients with valvular heart 
disease. 
Relationship of C-l 1 acetate clearance to noninvasive 
indexes of myocardial oxygen demand. Although there 
was a significant correlation (r = 0.73, p = 0.0001) 
between C-11 clearance rate constants and the gra- 
dient-corrected rate-pressure product, considerable 
scatter around the line of identity was observed (Fig. 
5). This was in marked contrast to the close correla- 
tion observed between these parameters in normal 
subjects studied over a similar range of rate-pressure 
products attained at rest and during exercise in a 
study by Armbrecht et a1.6 and at rest and during 
dobutamine infusion in a study by Henes et a1.7 In 
both of these studies, correlation coefficients of more 
than 0.9 were found. This discrepancy may be ex- 
plained by the technical difficulties of assessing 
“true” oxygen demand in patients with valvular 
heart disease. Although echocardiography was per- 
formed within hours of the positron emission tomo- 
graphic study in the majority of patients, small 
changes in hemodynamic status and heart rate be- 
tween the studies may have contributed to increased 
data scatter. On the other hand, rate-pressure prod- 
uct may be less predictive of myocardial oxygen de- 
mand in patients with valvular heart disease and 
C-11 acetate kinetics may more accurately reflect 
oxygen consumption. 
These patients are characterized by varying de- 
grees of left ventricular hypertrophy, dilatation, and 
function, which are known to affect load independent 
of myocardial oxygen consumption. Because C-11 
acetate kinetics probably reflect all determinants of 
oxygen demand, changes in contractility or wall 
stress would alter the relationship between oxygen 
consumption and rate-pressure product. Patients 
with aortic regurgitation had a larger range of cavity 
sizes and left ventricular ejection fractions than pa- 
tients with aortic stenosis or normal subjects (Table 
I), thus explaining the lack of significant correlation 
between C-11 acetate clearance rate constants and 
the rate-pressure product in the patients. 
Independent of the correlation of individual data, 
the average C-11 clearance rate constants normalized 
for gradient-corrected rate-pressure product were 
lower in patients with pressure- or volume-loaded left 
ventricles than in our normal subjects. A possible ex- 
planation for this finding is that myocardial adapta- 
tion by hypertrophy may reduce myocardial oxygen 
demand under conditions of chronically increased 
loading by reducing wall stress as suggested by 
results of previous experimental studies.18 This pos- 
sibility is supported by the observation that C-11 ac- 
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Fig. 7. C-11 acetate clearance rate constants are pre- 
sented for patients with normal and low left ventricular 
ejection fractions (LVEF) and for normal subjects. Mean 
C-11 acetate clearance rate constants (hatched circles) 
were slightly higher in patients with LVEF GO%, but 
there was considerable overlap between patients with nor- 
mal and low left ventricular ejection fractions. 
etate clearance rate constants normalized for left 
ventricular wall stress were not significantly different 
and were in fact slightly higher in patients with aor- 
tic stenosis compared to those with aortic regurgita- 
tion, whereas C-11 clearance rate constants normal- 
ized for rate-pressure product were lower in aortic 
stenosis than in aortic regurgitation. Furthermore, in 
15 patients with normal left ventricular ejection 
fractions, C-11 acetate clearance rate constants nor- 
malized for either mean wall stress index or the 
product of heart rate and the mean wall stress index 
were not significantly different from values in normal 
subjects. 
An alternative explanation for apparently de- 
creased myocardial oxygen consumption relative to 
that expected based on rate-pressure product would 
be decreased contractility. Since neither rate-pres- 
sure product nor wall stress measurements assess 
contractility, they could theoretically overestimate 
oxygen consumption in the failing heart. In keeping 
with this hypothesis, C-11 acetate clearance rate 
constants normalized for both gradient-corrected 
rate-pressure product and mean wall stress index 
were lower in patients with low left ventricular ejec- 
tion fractions than in patients with preserved ejec- 
tion fractions, although neither reached statistical 
significance. However, C-11 acetate clearance rate 
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constants normalized for the product of heart rate 
and mean left ventricular wall stress index were sig- 
nificantly lower in the five patients with ejection 
fractions -GO % than in patients with normal ejection 
fractions and also in comparison to normal subjects 
(2.3 k 0.4 X 10e6 vs 4.3 f 0.9 X 10d6 and 4.6 & 
0.8 X 10w6, p < 0.05). Additional studies that use in- 
vasive measurement of indexes reflecting the con- 
tractile state of the myocardium are required to as- 
sess the relationship between C-11 acetate kinetics 
and myocardial contractility. Initial results of animal 
studies suggest that changes in myocardial contrac- 
tility affect cardiac efficiency to a considerable ex- 
tent, as defined by C-11 acetate kinetics and cardiac 
work.20 
Regional C-l 1 acetate clearance variation with in- 
creased global loading. C-11 acetate clearance kinet- 
ics provide a unique assessment of regional myocar- 
dial oxidative metabo1ism.l’ In contrast to normal 
subjects who had marginally higher C-11 acetate 
clearance rate constants in the septum, both pressure 
and volume overload were associated with relatively 
increased C-11 acetate clearance rate constants in the 
free wall compared to the ventricular septum 
(p < 0.05). The findings in normal subjects are con- 
sistent with our previous observations in normal 
subjects in which more elaborate regional analysis 
algorithms were used, which showed a small but sig- 
nificant inhomogeneity of C-11 acetate clearance rate 
constants with relatively increased septal values.ll 
Our data suggest that although there is increased 
loading of the entire ventricle, there may be regional 
changes in the distribution of myocardial oxidative 
metabolism, which may reflect either variation in 
wall stress or regional changes in contractility. The 
ratio of septal to lateral wall C-11 acetate clearance 
rate constants was significantly lower in patients with 
low left ventricular ejection fractions than in normal 
subjects and patients with normal ejection fractions. 
Whether such changes in regional oxidative metabo- 
lism are useful in determining disease progression 
requires further definition. 
Clinical implications. Treatment of patients with 
chronic pressure or volume overload of the left ven- 
tricle is generally predicated by symptoms. However, 
there are many clinical settings involving pathologic 
loading of the left ventricle as a result of valvular 
disease in which the optimal timing and type of ther- 
apeutic intervention remain poorly defined.21-27 
Whereas it is clear that the prognosis after valve re- 
placement is generally good when preoperative ejec- 
tion fraction is maintained,28-32 prediction of post- 
operative function and hence selection of patients for 
surgery remains problematic in patients with im- 
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paired left ventricular contractile function.33 The 
state of myocardial contractility appears to be a cru- 
cial factor in determining the therapeutic outcome of 
valve replacement in such patients23y 26, 27! 33-35 but 
can be difficult to assess in patients with chronic my- 
ocardial overload.23, 36-38 
Conceptually, direct measurement of myocardial 
oxygen consumption with C-11 acetate combined 
with determination of load-dependent parameters of 
myocardial oxygen demand could provide a sophisti- 
cated experimental method to derive information re- 
garding the status of load-independent determinants 
of oxygen demand or myocardial efficiency as we have 
demonstrated in animal studies.20 Validation of this 
approach in humans will require determination of the 
regression between C-11 acetate clearance rate con- 
stants and true myocardial oxygen consumption in 
the human heart with simultaneous evaluation of 
load-dependent and load-independent parameters of 
oxygen demand and external cardiac work. 
Limitations. C-11 acetate kinetics have been vali- 
dated as a marker of myocardial oxygen consumption 
primarily in normal canine and human hearts. C-11 
acetate metabolism may be altered in the failing 
heart and thus the relationship between C-11 clear- 
ance kinetics and oxygen consumption differs from 
that in the normal myocardium. Results of recent 
studies indicate that C-11 acetate equilibrates with 
intermediates of the tricarboxylic acid cycle such as 
glutamate. 3g, 4o Changes in the glutamate tissue con- 
centration therefore may affect the rate of C-11 
clearance in the form of C-11 carbon dioxide. Exper- 
iments in the acutely ischemic myocardium have 
demonstrated a maintained relationship between the 
C-11 clearance rate and MVOs, but no data compar- 
ing C-11 acetate kinetics and directly measured ox- 
ygen consumption are available in the failing human 
heart.6, 41 
The use of the left ventricular ejection fraction to 
stratify patients into subgroups presumed to have 
normal and abnormal contractile function is not 
ideal, since this parameter does not reflect contrac- 
tility alone. As can be seen from mean data for 
patients with and without normal left ventricular 
ejection fractions (Table III), wall stress tended to be 
higher in those with a low ejection fraction whereas 
left ventricular mass tended to be lower. Such fea- 
tures raise the possibility that afterload mismatch37 
may be an important factor in the depressed ejection 
fraction in these patients rather than depressed con- 
tractility. Direct determination of myocardial con- 
tractility was not performed in this study, and the 
presence of depressed contractility as a cause of the 
relatively reduced C-11 acetate clearance rate con- 
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stants compared with rate-pressure product and wall 
stress in patients with low ejection fractions is con- 
jectural but warrants further studies with invasive 
measurements of contractility. 
Conctusions. Positron emission tomography in com- 
bination with C-11 acetate provides a unique nonin- 
vasive characterization of both regional and global 
myocardial oxidative metabolism. We have applied 
this approach to the investigation of patients with 
aortic valve disease. The data presented suggest that 
C-11 clearance kinetics after administration of C-11 
acetate reflect myocardial oxygen consumption in the 
pressure- or volume-loaded heart, just as they do in 
the normal heart.4-7 However, absolute C-11 clear- 
ance rate constant values in a given patient appear to 
offer relatively little incremental information com- 
pared to more readily obtained noninvasive param- 
eters of myocardial oxygen demand, since these val- 
ues generally reflect loading of the ventricle. If, how- 
ever, accurate characterization of load-dependent 
determinants of myocardial oxygen demand were 
obtained and then compared with myocardial oxygen 
consumption, as reflected by C-11 acetate clearance, 
it might be possible to assess the status of load-inde- 
pendent determinants of oxygen demand. Serial 
comparison of C-11 acetate clearance rate constants 
with parameters of oxygen demand may provide a 
means to noninvasively define and follow metabolic 
performance in the setting of pathologic volume or 
pressure loading. 
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